A Modified Nucleoside 6-thio-2′-deoxyguanosine Exhibits Anti-tumor Activity in Gliomas

Four patient-derived xenografts, two patient-derived organoi and two xenografts of human glioma cell lines were used to further investigate the therapeutic efficacy of 6-thio-2′-deoxyguanosine.